Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol
Conde, S.; Corral, C.; Lissavetzky; Darias, V.; Martin, D.
Il Farmaco; Edizione Scientifica 41(1): 80-88
1986
ISSN/ISBN: 0430-0920 PMID: 2869971 Document Number: 551
The synthesis of the thiophenic analogue of metoprolol (VI) and of its related compound (VII) are described. Except for cardioselectivity at low doses, the thiophenic analogue of metoprolol behaves in a very similar way as this compound in all the aspects considered in a preliminary pharmacological study.
Document emailed within 1 workday

Related Documents
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Shanks, R.G. 1981: Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs European Heart Journal 2(3): 253-255
Sivam, S.P.; Seth, S.D. 1978: Metoprolol--a new cardioselective beta adrenoceptor antagonist in experimental cardiac arrhythmias Indian Journal of Medical Research 68: 176-182
Hoffmann, K. 1979: Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol Acta Pharmaceutica Suecica 16(2): 160
Gesquière, J.C.; Dhaisne, J.M.; Marcinal-Lefebvre, A.; Bar, D.; Vincent, A.; Dupuis, B. 1982: Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity Annales Pharmaceutiques Francaises 40(3): 251-257
Conway, J. 1980: The antihypertensive action of beta-adrenoceptor blocking agents Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Balsamo, A.; Lapucci, A.; Macchia, B.; Macchia, M.; Orlandini, E.; Rossello, A.; Ferni, G.; Pinza, M. 1995: Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines Farmaco 50(4): 239-243
Mostaghim, R.; Maddox, Y.T.; Ramwell, P.W. 1986: Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents Journal of Pharmacology and Experimental Therapeutics 239(3): 797-801
Hellenbrecht, D.; Gortner, L. 1976: Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents Polish Journal of Pharmacology and Pharmacy 28(6): 625-630
Schneider, R.E.; Bishop, H.; Kendall, M.J.; Quarterman, C.P. 1981: Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents International Journal of Clinical Pharmacology Therapy and Toxicology 19(4): 158-162
Keith, R.A.; Hwang, T.F.; Murthy, V.S.; Kau, S.T.; Salama, A.I.; Giles, R.E. 1989: ICi 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues Journal of Pharmacology and Experimental Therapeutics 248(1): 240-248
Hamilton, T.C.; Parkes, M.W. 1977: Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology Arzneimittel-Forschung 27(7): 1410-1417
Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Elonen, E. 1975: Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice Medical Biology 53(4): 231-237
Tsuji, Y.; Soeda, S.; Ochiai, T.; Mishima, K.-i.; Iwasaki, K.; Fujiwara, M.; Yokomatsu, T.; Murano, T.; Akiyama, T.; Shibuya, S.; Shimeno, H. 2002: Synthesis of sphingomyelin analogues as a sphingomyelinase inhibitor and the application as a blocking agent of extracellular stress signaling Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 67p-69p